Navigation Links
Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007
Date:11/7/2007

The Company's EBITDA and net earnings increase by almost 75% and by 52%

respectively during the period

All amounts are in U.S. dollars

QUEBEC CITY, Nov. 7 /PRNewswire-FirstCall/ - Atrium Innovations Inc. (TSX: ATB) today announced that it had revenues of US$100.9 million for the third quarter ended September 30, 2007, up 37.7% from US$73.3 million for the corresponding quarter in 2006. Earnings before interest, taxes, depreciation and amortization (EBITDA) for the third quarter of 2007 were US$19.2 million, up 74.8% from US$11.0 million for the same period in 2006. Net earnings increased 52.2% to US$9.8 million for the quarter ended September 30, 2007, compared to US$6.4 million for the same period last year. Fully diluted earnings per share for the third quarter of 2007 were up 50.0% to US$0.30 per share compared to US$0.20 per share for the same period in 2006.

For the nine-month period ended September 30, 2007, revenues were US$272.0 million up 21.7% from US$223.6 million for the corresponding period in 2006. EBITDA for the first nine months of 2007, was US$46.9 million, an increase of 37.7% compared to the US$34.0 million for the same period last year. Net earnings increased 27.4% to US$25.0 million generating a fully diluted earnings per share of US$0.76, compared to US$19.6 million and US$0.60 earnings per share for the first nine months of 2006.

"Our results for the last quarter include an increase of almost 75% in EBITDA. This demonstrates the soundness of our development strategy. Our organic growth as well as our targeted acquisition plan in highly fragmented markets are the corner stone of our success. In keeping with this strategy, we completed on July 12, 2007, the acquisition of Mucos Emulsions GmbH ("Mucos"), our largest acquisition to date. Mucos provides us with a high-performance European platform that will be used as a strategic lever and will allow us to pursue our growth in
'/>"/>

SOURCE Atrium Innovations Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Atrium Innovations Announces Management Changes
2. Atrium Innovations to Hold 2007 Third Quarter Financial Results Conference Call and Webcast on November 8
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Dallas, Texas (PRWEB) December 17, 2014 ... research on Global Quartz Tubing industry. For an ... information, definition, classification, application, industry chain structure, industry ... domestic quartz tubing industry has witnessed ... through a number of acquisitions. This report mentions ...
(Date:12/17/2014)... Gene synthesis and bioengineering company ... into a technology access and services agreement with ... proprietary protein engineering technology, known as “ProteinGPS®” to ... extremely excited that the global leader ADM has ... bioengineering technology has now been validated through many ...
(Date:12/17/2014)...  Vermillion, Inc. (NASDAQ: VRML ), a ... the next step in its expanded strategy to rebuild ... the naming of current Chief Operating Officer, Valerie ... current Chairman of the Board and CEO James ... changes are effective January 1, 2015. "Jim ...
(Date:12/17/2014)... 17, 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... acquisition, development and commercialization of innovative therapeutics addressing cancer ... with a primary commercial focus on China ... a Type C meeting with the U.S. Food and ... held in February 2015.  During this meeting the Company ...
Breaking Biology Technology:2020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5
... This Thursday, the 17th annual SBIR/STTR Conference will be ... at the Crowne Plaza in Madison, 4402 E. Washington. ... Business Innovation Research (SBIR) and Small Business Technology Transfer ... billion federal dollars available to small businesses for technological ...
... Corporation, a growth company of ... its Cequent Transportation Accessories Group ... provider of zinc plating services. ... Wis. and has been a ...
... worldwide leader in e-document delivery ... and VSI-FAX(R) product families, announces ... This new solution allows Lotus ... efficiently, effectively, and economically with ...
Cached Biology Technology:Annual Conference Honors Tech Grant Winners 2
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the ... 2015-2019" report to their offering. ... is the adoption of multimodal biometric systems. Multimodal ... an individual for verification and identification purposes. This ...
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical ... building for its School of Medicine. Funding for this ... capital campaign that will be publicly launched next summer. ... located in the former 60 series R.J. Reynolds Tobacco ... Quarter. Construction will begin immediately with plans to be ...
(Date:12/5/2014)... , Dec. 4, 2014  Tute Genomics, a ... $2.3 million in Series A1 funding led by UK-based ... also participated in the investment round. "We ... healthcare community adopts next-generation sequencing and seeks new approaches ... Reid Robison , MD MBA, and CEO of ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
... that go on to form the face, skull and ... is determined much earlier in development than previously thought, ... according to a recent study published in the journal ... with three different technologies -- immunostaining of proteins, in ...
... the original press release , A motion-triggered camera trap set ... a rhino in the wild on the island of Borneo, World ... rhino is believed to be one of a population of as ... last year in the interior forests of Sabah, Malaysia, an area ...
... inhibits proliferation of a broad range of lethal malignant ... published in the May issue of Cancer Cell, shed ... likely to play a role in cancer progression. This ... inhibitors must display a broad reactivity to effectively attenuate ...
Cached Biology News:Making a face: A new and earlier marker of neural crest development 2WWF captures first-ever photo of wild rhino on Borneo 2Unique dual target specificity of kinase inhibitor key for success against cancer 2
... whose sequence is derived from bovine rhodopsin protein. The ... C - S(338) - K - T - E - ... P - A(348). This peptide may be used ... reacts with this product and bovine rhodopsin, catalog # PA1-729. ...
... Dual-Binary Analytical System more than doubles the ... LC/MS. The fast analysis cycles of the ... to 100% in tandem mode. Difficult separations ... Using backflush or heartcut configurations, on-line sample ...
... Components in this kit are prepared with ... Biochains Mitochondria Isolation Kit is designed ... a fast and easy way. One kit ... 100 isolations (enriching mitochondria from 10 ...
... Highly-purified, endotoxin-free plasmid DNA preparations are ... in quantities from 1mg to multi-gram ... as large-scale (100mg-multi-gram) preparations are made ... preparation is formulated according to customer ...
Biology Products: